Neurocrine Biosciences
Clinical trials sponsored by Neurocrine Biosciences, explained in plain language.
-
New drug shows promise for kids with Sleep-Related epilepsy
Symptom relief CompletedThis study tested a new medicine called NBI-827104 in 24 children with a rare form of epilepsy that causes constant brain activity during sleep. The goal was to see if the drug could reduce that activity and improve safety. Children took the drug or a placebo once daily for 13 we…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 26, 2026 11:05 UTC
-
New hope for schizophrenia: valbenazine shows promise in phase 3 trial
Symptom relief CompletedThis study tested whether adding valbenazine to standard antipsychotic medication helps reduce schizophrenia symptoms in adults who still have symptoms despite treatment. 442 participants received either valbenazine or a placebo for 10 weeks. The main goal was to see if valbenazi…
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 26, 2026 11:02 UTC